INTERNATIONAL VACCINE INSTITUTEPub 78
Pub 78
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$101,596,804
Cash & Equivalents
60%
Property, Plant, & Equipment (net)
14%
Receivables (Non-Related)
13%
Other Assets
13%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Liabilities in 2024 (Year End)
$7,004,180
Payables & Accruals
>99%
Other Liabilities
<1%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$57,393,380
$60,602,981
+6%
Receivables (Non-Related)
$25,510,041
$12,967,866
-49%
Related-Party Receivables
$0
$0
-
Inventories
$0
-
-
Prepaid Expenses
$531,156
$602,102
+13%
Investments
$0
-
-
Property, Plant, & Equipment (net)
$8,246,069
$14,606,485
+77%
Other Assets
$13,109,610
$12,817,370
-2%
Total Assets
$104,790,256
$101,596,804
-3%
Liabilities
2023
2024
Change
Payables & Accruals
$5,102,041
$6,960,074
+36%
Grants Payable
$0
-
-
Deferred Revenue
$0
-
-
Tax-Exempt Bond Liabilities
$0
-
-
Custodial & Escrow Liabilities
$0
-
-
Notes Payable / Debt (Non-Related)
$0
-
-
Related-Party Payables
$0
$0
-
Other Liabilities
$50,173
$44,106
-12%
Total Liabilities
$5,152,214
$7,004,180
+36%
Net assets
2023
2024
Change
Restricted Net Assets
$49,445,108
$47,261,803
-4%
Unrestricted Net Assets
$50,192,934
$47,330,821
-6%
Net assets
2023
2024
Change
Net assets
+$99,638,042
+$94,592,624
-5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)